Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000902664-19-004570
Filing Date
2019-12-12
Accepted
2019-12-12 16:03:25
Documents
1
Effectiveness Date
2019-12-12
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11206
  Complete submission text file 0000902664-19-004570.txt   12396
Mailing Address C/O ORBIMED GENESIS GP LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address C/O ORBIMED GENESIS GP LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
OrbiMed Genesis Fund, L.P. (Filer) CIK: 0001796304 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-355430 | Film No.: 191281913